A meta-analysis of randomized controlled trials (RCT) suggested that ARB are associated with an increased risk of new cancer diagnoses, while another meta-analysis of observational studies did not find significant associations between the use of ACE inhibitors or ARB and the risk of cancer, noting that the previous meta-analysis of RCT had a short duration of follow-up [9, 18]. This evidence concerns the gene ACE and cancer.